Anti-TNF treatment advised for pregnant women and children with bowel disease

Article

Pregnant women and children with inflammatory bowel disease (IBD) should be treated with anti-tumor necrosis factor therapy because active disease poses a greater risk than most medications used to induce and maintain remission, urges the new London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn?s and Colitis Organisation.

 

Pregnant women and children with inflammatory bowel disease (IBD) should be treated with anti-tumor necrosis factor therapy because active disease poses a greater risk than most medications used to induce and maintain remission, urges the new London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn’s and Colitis Organisation.

The authors recommend infliximab, adalimumab, or certolizumab during pregnancy. The safety of natalizumab during pregnancy isn’t known. Infliximab and certolizumab are apparently safe during breastfeeding; no safety data are available for adalimumab. For children, infliximab (scheduled infusions rather than episodic therapy) and adalimumab are effective in Crohn’s disease and ulcerative colitis; natalizumab is also effective in Crohn’s disease. No data exist for certolizumab in children.

Lead author Uma Mahadevan, MD, of the University of California San Francisco Center for Colitis and Crohn’s Disease suggests that the risk of the untreated disease is greater than the risk of most medications. During pregnancy, active disease can cause preterm birth or miscarriage. In childhood, lack of treatment can adversely affect physical and emotional growth and development.

The position statement recommends vaccinating infants who have been exposed to biological therapy in utero according to standard schedules during the first 6 months of life. Live-virus vaccines such as rotavirus are contraindicated, however, because of the risk of infection. Inactivated vaccines are considered safe, even for immunocompromised children.

The statement was published online December 14 in the American Journal of Gastroenterology.

Recent Videos
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Henri M. Rosenberg, MD
Medical experts personalize contraceptive options for complex cases | Image Credit: findcare.ahn.org
Study explores the limits of neighborhood data in predicting preterm birth | Image Credit: linkedin.com
Barbed suture reduces blood loss in hysterectomy | Image Credit: linkedin.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.